Microbix Advances Test-Ingredient Manufacturing Capabilities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: MBX) | Delayed: 52.48 -2.52 (4.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.00 | 52 Week High | $ | |||
| Open | $55.95 | 52 Week Low | $ | |||
| Day High | $57.00 | P/E | N/A | |||
| Day Low | $51.73 | EPS | $ | |||
| Volume | 424,990 | |||||
| Microbix Biosystems, Inc. (AMEX: MBXBF) | Delayed: 0.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $0.28 | |||
| Open | $0.22 | 52 Week Low | $0.14 | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.22 | EPS | $0.00 | |||
| Volume | 1,263,809 | |||||
